The monoclonal antibody Lecanemab (brand name Leqembi®) has shown compelling efficacy in slowing cognitive decline by approximately 50% in patients with early stage …
Category:
Health
-
-
-
A Potential Breakthrough Against Alzheimer’s Disease Scientists are exploring a CRISPR based gene therapy that targets genetic causes of Alzheimer’s disease, offering potential …
-
-
-
GlobalHealth
Hunger‑Related Deaths Surge in Gaza Amid Blockade and Escalating Conflict
by Adminby AdminA mounting humanitarian emergency has gripped Gaza as doctors and health officials report a wave of deaths from starvation and malnutrition, especially impacting …
